Research into colloidal particles for drug delivery has, in the past f
ew years, begun to focus on the delivery of biopolymers such as peptid
es, proteins and plasmids, Progress is being made in the sustained del
ivery of biopolymers and in the development of particulate delivery sy
stems for alternative routes of administration, such as the lungs or n
asal cavity.